Skip to main content
OpenTrials
Completed

NCT Number: NCT01016080

Role of Oral Glutathione in Skin Whitening

Oral and intravenous glutathione have been used widely to whiten the skin. The investigators tested this hypothesis by giving oral glutathione for 4 weeks to medical students.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

King Chulalongkorn Memorial Hospital

Bangkok, 10330, Thailand

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy medical students

Exclusion criteria

  • history of skin cancer, especially melanoma
  • consumption of any preparations containing glutathione within 1 month of enrollment
  • pigmentary disorders or any dermatoses

Treatment and study plan

Glutathione

Drug

250 mg capsules, twice daily, orally

Placebo

Drug

250 mg capsules, twice daily, orally

Primary outcomes

  1. Skin melanin index

    Time frame: 4 weeks

Sponsors and collaborators

Lead sponsor

Chulalongkorn University

Other

Registry information

Official study title

Glutathione as an Oral Whitening Agent: a Randomized, Double-blind, Placebo-controlled Study

Important dates

Study start
2009
Primary completion
2009
Study completion
2009
First posted
Nov 18, 2009
Registry last updated
Nov 18, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.